Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc. | 15 | 4 | 1 | 0 | €7.76 | €13.09 | 68.722% |
| Adverum Biotechnologies Inc. | 9 | 0 | 1 | 0 | €1.38 | €20.55 | 1388.986% |
| Abeona Therapeutics Inc. | 6 | 1 | 2 | 0 | €4.72 | €19.31 | 309.100% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 34.172% |
| Viking Therapeutics Inc | 5 | 0 | 0 | 0 | €60.74 | - | - |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €103.85 | - | - |
| Lemaitre Vascular Inc | 2 | 0 | 0 | 0 | €78.50 | - | - |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €54.00 | €50.00 | -7.407% |
| Pulmatrix Inc. | 3 | 1 | 2 | 0 | €1.80 | €6.08 | 237.611% |
| Aclaris Therapeutics Inc | 1 | 0 | 0 | 0 | €1.29 | €3.00 | 133.463% |
| Kura Oncology Inc | 1 | 0 | 0 | 0 | €19.43 | €20.00 | 2.960% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | €2.08 | €6.45 | 210.221% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €2.90 | €5.55 | 91.503% |
| Intellia Therapeutics Inc | 17 | 1 | 0 | 0 | €24.40 | €60.53 | 148.092% |
| Syros Pharmaceuticals Inc. | 7 | 1 | 0 | 0 | €5.60 | €13.70 | 144.702% |
| AnaptysBio Inc | 9 | 1 | 1 | 0 | €34.20 | €46.24 | 35.205% |
| R1 RCM Inc. | 23 | 0 | 3 | 0 | €11.80 | €17.21 | 45.869% |
| G1 Therapeutics | 21 | 1 | 0 | 0 | €3.64 | €10.54 | 189.813% |
| Kala Pharmaceuticals Inc. | 5 | 0 | 0 | 0 | €6.40 | €19.50 | 204.664% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
| Rhythm Pharmaceuticals | 16 | 0 | 1 | 0 | €45.60 | €46.37 | 1.689% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €196.65 | €186.59 | -5.116% |
| Novavax Inc. | 4 | 1 | 0 | 1 | €15.76 | €22.18 | 40.679% |
| Inogen Inc. | 1 | 2 | 0 | 1 | €8.90 | €6.53 | -26.579% |
| Sangamo Therapeutics Inc. | 13 | 17 | 1 | 5 | €0.79 | €4.10 | 417.030% |